FILTER
FILTERED INTERVIEW RESULTS
Michael Zahra
FORMER PRESIDENT & CEO, DRONE DELIVERY CANADA
"Remote projects may prefer to isolate and limit the number of external individuals visiting as a precaution to avoid the virus spreading, but they need to maintain their supply chain so drones are a perfect unmanned logistics solution."
Olivier Rousset
MARKET MANAGER SPECIAL PARTS, PROFORM
Proform specializes in tube bending, forming, assembling, hydroforming manufacturing and design, for aerospace and defense.
Bernard Lavergne
BERNARD LAVERGNE, PRESIDENT, SN AUVERGNE AERONAUTIQUE
SN Auvergne Aeronautique is expanding its scope, using the synergies created with the Figeac Aero Group.
Franck Picard
OPERATIONAL DIRECTOR, ACNIS INTERNATIONAL
A conversation around the titanium alloy distribution in Europe’s aerospace industry.
Jean-Michel Deck
BUSINESS DEVELOPMENT, COMPOSE
Compose designs and manufactures tools to process thermoplastics and composite materials.
Eric Pisani
CEO, SINTEX NP
Sintex is looking to expand its offering of thermoplastic composites to serve the aerospace sector worldwide.
Jocelyn Lardet
INDUSTRIAL DIRECTOR, JET CUT
Jet Cut is the European leader in water jet cutting services for metal and composite aerospace materials.
Patrick Besnier
PRESIDENT, DBC
DBC speaks to GBR about the business environment in the Auvergne-Rhône-Alpes aero-space sector.
Nicolas Chantier
MARKETING MANAGER, TELEDYNE e2v
E2v, a British technology system and components company, was fully acquired by Teledyne, a global enabling technology company from California, in March 2017.
Manuel Collet & Régis Dufour
VP PROSPECTION AND DEVELOPMENT & DG, INGÉNIERIE @ LYON
Ingénierie @ Lyon offers a wide scope of research facilities for private companies of all sizes that are looking to innovate in the regions aerospace cluster.
MACIG
SPANISH
SUBSCRIBE TO OUR NEWSLETTER
RECENT PUBLICATIONS
United States Life Sciences 2025 - Digital Interactive
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
PARTNER EVENTS
SUBSCRIBE TO OUR
NEWSLETTER
- Get GBR content delivered to your inbox
- Receive industry based news
- Completely free, e-mail only
